Related Experiment Video
Updated: Oct 4, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
In PrEP: Long-acting antivirals for HIV prevention
1Department of Veterinary Biosciences, Department of Microbial Infection & Immunity, The Ohio State University, Columbus, OH, USA.
Abstract:
Two recent publications (Vidal et al., 2021; Xue et al., 2022) report highly potent inhibitors as candidates for HIV pre-exposure prophylaxis (PrEP). They provide strong evidence that administration of long-acting capsid or fusion inhibitors as PrEP offers robust protection against simian-human immunodeficiency virus in the rhesus macaque model of HIV infection.
Related Concept Videos
Retrovirus Life Cycles
Size and Structure of Viral Genomes
Retroviruses
Viruses with RNA Genomes
Sexually Transmitted Infections
Subviral Agents

